Organoruthenium carbide complexes as precatalysts for olefin metathesis

US11291983B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11291983-B2
Application numberUS-202017024778-A
CountryUS
Kind codeB2
Filing dateSep 18, 2020
Priority dateSep 18, 2019
Publication dateApr 5, 2022
Grant dateApr 5, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments in accordance with the present invention encompass an organoruthenium compound of the formula (I) or formula (II):Wherein X, L, R1, R2, R3, R4, R5, Ar1 and Ar2 are as defined herein. Also disclosed herein are the use of organoruthenium compound of the formula (I) or formula (II) as (pre)catalysts for the olefin metathesis reactions, as well as to the process for carrying out the olefin metathesis reaction.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of the formula I: wherein: X is chlorine, bromine or iodine; L is PR 3 , where each R is independently selected from the group consisting of isopropyl, sec-butyl, tert-butyl, cyclohexyl, bicyclo(C 5 -C 10 )alkyl, phenyl, benzyl, isopropoxy, sec-butoxy, tert-butoxy, cyclohexyloxy, phenoxy and benzyloxy; R 1 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl, tert-butyl, substituted or unsubstituted cyclohexyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl and substituted or unsubstituted naphthyl; Ar 1 is selected from the group consisting of substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl and substituted or unsubstituted naphthyl; wherein said substituents are selected from the group consisting of methyl, ethyl, iso-propyl, tert-butyl and phenyl; and with the proviso that when X is chlorine, R 1 is not 2,4,6-trimethylphenyl. 2. The compound according to claim 1 , wherein: X is chlorine or iodine; R 1 and Ar 1 are both substituted phenyl; and L is PR 3 , where each R is independently selected from the group consisting of isopropyl, sec-butyl, tert-butyl, cyclohexyl and phenyl. 3. The compound according to claim 1 , wherein: X is chlorine; R 1 and Ar 1 are independently selected from the group consisting of phenyl, 2-methylphenyl, 2,4-dimethylphenyl, 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2-ethylphenyl, 2,4-diethylphenyl, 2,6-diethylphenyl, 2,4,6-triethylphenyl, 2-isopropylphenyl and 2,6-diisopropylphenyl; and L is tri(isopropyl)phosphine or tricyclohexylphosphine. 4. The compound according to claim 1 , wherein: X is chlorine; R 1 and Ar 1 are independently selected from the group consisting of phenyl, 2,4-dimethylphenyl, 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2,4-diethylphenyl, 2,6-diethylphenyl, 2,4,6-triethylphenyl, 2-isopropylphenyl and 2,6-diisopropylphenyl; and L is tricyclohexylphosphine. 5. The compound according to claim 1 , wherein: X is iodine; R 1 and Ar 1 are independently selected from the group consisting of 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2,6-diethylphenyl, 2,4,6-triethylphenyl and 2,6-diisopropylphenyl; and L is tricyclohexylphosphine. 6. The compound according to claim 1 , which is selected from the group consisting of: 1,3-bis(2,4,6-trimethylphenyl)-imidazolidin-2-ylidene-tricyclohexylphosphine-ruthenium carbide diiodide; 1,3-bis(2,6-diisopropylphenyl)-imidazolidin-2-ylidene-tricyclohexylphosphine-ruthenium carbide dichloride; 1,3-bis(2,6-diisopropylphenyl)-imidazolidin-2-ylidene-tricyclohexylphosphine-ruthenium carbide diiodide. 7. A process for carrying out a metathesis reaction of olefins, comprising contacting at least one olefin with the compound of claim 1 as a precatalyst. 8. The process according to claim 7 , wherein the metathesis reaction is carried out in an organic solvent. 9. The process according to claim 8 , wherein the organic solvent is selected from the group consisting of dichloromethane, dichloroethane, toluene, ethyl acetate and a mixture in any combination thereof. 10. The process according to claim 7 , wherein the metathesis reaction is carried out in the presence of a chemical activator. 11. The process according to claim 7 , wherein the chemical activator is a Bronsted or Lewis acid or a halo-derivative of alkane or silane.

Assignees

Inventors

Classifications

  • Ruthenium · CPC title

  • at a cyclic carbon-to-carbon double bond · CPC title

  • Phosphines {, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands} · CPC title

  • Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring · CPC title

  • with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11291983B2 cover?
Embodiments in accordance with the present invention encompass an organoruthenium compound of the formula (I) or formula (II):Wherein X, L, R1, R2, R3, R4, R5, Ar1 and Ar2 are as defined herein. Also disclosed herein are the use of organoruthenium compound of the formula (I) or formula (II) as (pre)catalysts for the olefin metathesis reactions, as well as to the process for carrying out the ole…
Who is the assignee on this patent?
Apeiron Synthesis Sa, Promerus Llc
What technology area does this patent fall under?
Primary CPC classification B01J31/2273. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).